Carregant...
Prasugrel in critically ill patients
While prasugrel is indicated for the treatment of myocardial infarction, its effects in the most severely affected patients requiring intensive care is unknown, so that we measured the antiplatelet effects and sparse pharmacokinetics of prasugrel in critically ill patients. Twenty-three patients adm...
Guardat en:
| Publicat a: | Thromb Haemost |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Schattauer GmbH
2017
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6292180/ https://ncbi.nlm.nih.gov/pubmed/28692105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1160/TH17-03-0154 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|